Intravenous (IV) Solutions Global Market Report 2022: Alarming Rise in Diabetes Incidence Worldwide Fuels Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Intravenous (IV) Solutions – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Intravenous (IV) Solutions Market to Reach $16 Billion by 2027

Amid the COVID-19 crisis, the global market for Intravenous (IV) Solutions estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$16 Billion by 2027, growing at a CAGR of 6.8% over the period 2020-2027. Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$11 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.9 Billion, While China is Forecast to Grow at 8.4% CAGR

The Intravenous (IV) Solutions market in the U.S. is estimated at US$3.9 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 8.4% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Select Competitors (Total 67 Featured)

• Amanta Healthcare
• Anhui Medipharm Co., LTD.
• Axa Parenterals Ltd.
• B. Braun Melsungen Ag
• Baxter International Inc.
• Fresenius Kabi AG
• Grifols, S.A.
• ICU Medical, Inc.
• JW Life Science
• Otsuka Pharmaceutical Co. Ltd.
• Pfizer Inc.
• Salius Pharma Private Limited.
• Vifor Pharma Management Ltd.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
• Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
• Rising Cancer Incidence and Need for Nutritional Support
• Alarming Rise in Diabetes Incidence Worldwide
• Unrelenting Threat of HIV/AIDS Infection
• Nutritional Management of Patients with Neurological Diseases
• Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
• Growing Numbers of Pre-term Births Drives Demand for IV Solutions
• Demand Rises for Home Intravenous Nutritional Therapies
• Premixed IV Nutrition: A Step towards Safer Medication Practices
• Premixed Formulations Present Efficient Delivery System
• Iron Replacement Therapies: Potential for Growth
• Growing Demand for Low-Cost Intravenous Nutrition Solutions
• COVID-19 Outbreak: Combating Medication Errors in IV Infusion
• Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market
• Increasing Healthcare Expenditure Creates Conducive Environment
• Challenges Confronting IV Solutions Market

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/xgvpe0

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900